Zemaira and dyspnoea Patient Reports February 11, 2012

Zemaira Side Effects Report #5751714-2
Zemaira side effect was reported by a Health Professional from UNITED STATES on May 14, 2008. Male patient, 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: bronchitis , chronic obstructive pulmonary disease, dyspnoea, pneumonia . Zemaira dosage: 60 UG/KG Q1W IV, 60 MG/KG Q1W IV, 60 MG/KG Q1W IV. During the same period patient was treated with ANTIBIOTICS, SINGULAIR, CELEBREX, LISINOPRIL, ADVAIR DISKUS, FLOMAX. Patient was hospitalized. Patient recovered.

Zemaira Side Effects Report #5781213-3
Zemaira side effect was reported by a Health Professional from UNITED STATES on May 29, 2008. Male patient, 64 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: bronchitis , chronic obstructive pulmonary disease, condition aggravated, dyspnoea, pneumonia . Zemaira dosage: unknown. During the same period patient was treated with ANTIBIOTICS, SINGULAIR, CELEBREX, LISINOPRIL, ADVAIR DISKUS, FLOMAX. Patient was hospitalized. Patient recovered.

Zemaira Side Effects Report #5773103-7
Zemaira side effect was reported by a Pharmacist from UNITED STATES on May 23, 2008. Male patient, 57 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: chest pain , dyspepsia, dyspnoea, fatigue, muscle spasms. Zemaira dosage: 60 MG/KG DAILY IV; 60 MG/KG DAILY IV. During the same period patient was treated with ADVAIR DISKUS, SPIRIVA, KOPENEX. Patient recovered.

Zemaira Side Effects Report #5877254-8
Zemaira side effect was reported by a Pharmacist from UNITED STATES on Aug 21, 2008. Male patient, 57 years of age, weighting 180.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Zemaira. After drug was administered, patient experienced the following side effects: chest pain , dyspepsia, dyspnoea, fatigue, feeling abnormal. Zemaira dosage: 60 MG/KG DAILY, IV. During the same period patient was treated with ADVAIR DISKUS, SPIRIVA, XOPENEX. Patient recovered.